• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素受体1阻滞剂可抑制高胆固醇血症兔主动脉瓣的动脉粥样硬化改变和内皮损伤。

Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits.

作者信息

Arishiro Kumiko, Hoshiga Masaaki, Negoro Nobuyuki, Jin Denan, Takai Shinji, Miyazaki Mizuo, Ishihara Tadashi, Hanafusa Toshiaki

机构信息

First Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan.

出版信息

J Am Coll Cardiol. 2007 Apr 3;49(13):1482-9. doi: 10.1016/j.jacc.2006.11.043. Epub 2007 Mar 21.

DOI:10.1016/j.jacc.2006.11.043
PMID:17397679
Abstract

OBJECTIVES

We sought to examine the effect of angiotensin receptor blocker (ARB) on the formation of lesions in the aortic valves of hypercholesterolemic rabbits.

BACKGROUND

Recently, atherosclerosis has been recognized as a mechanism that is responsible for calcific aortic stenosis. The effect of ARBs might help to prevent aortic stenosis because they have multiple antiatherosclerotic effects.

METHODS

Male Japanese white rabbits (n = 36) were separated as follows: control with chow diet (C) and vehicle (V) groups, both of which were fed a 1% cholesterol diet for 8 weeks, and an ARB group (A), which was fed a 1% cholesterol diet for 8 weeks with ARB (olmesartan, 1 mg/kg/day) for the last 4 weeks.

RESULTS

This dose of olmesartan did not affect either blood pressure or cholesterol levels. Dietary cholesterol induced fatty deposition with macrophage accumulation and osteopontin coexpression in valve leaflets, whereas ARB decreased macrophage accumulation (% area: V, 9.3 +/- 0.34; A, 1.4 +/- 0.30; p = 0.003) and osteopontin expression (p = 0.017). Angiotensin-converting enzyme was also up-regulated in V and decreased by olmesartan (p = 0.015). Immunohistochemistry with anti-CD31 antibody revealed that dietary cholesterol disrupted and olmesartan preserved endothelial integrity on the lesion-prone aortic side of the valve (% CD31-positive circumference: V, 30 +/- 3.7; A, 62 +/- 4.8; p = 0.003). Numbers of alpha-smooth muscle actin-positive myofibroblasts were increased in V and decreased by olmesartan (p = 0.003). Real-time polymerase chain reaction revealed that increased amounts of messenger ribonucleic acid for osteoblast-specific transcription factor core binding factor alpha-1 in V were diminished by olmesartan.

CONCLUSIONS

Atherosclerotic changes in the aortic valves of rabbits fed with cholesterol were inhibited by ARB, whereas endo-thelial integrity was preserved and transdifferentiation into myofibroblasts and/or osteoblasts in valve leaflets was inhibited.

摘要

目的

我们试图研究血管紧张素受体阻滞剂(ARB)对高胆固醇血症兔主动脉瓣病变形成的影响。

背景

最近,动脉粥样硬化已被认为是导致钙化性主动脉瓣狭窄的一种机制。ARB的作用可能有助于预防主动脉瓣狭窄,因为它们具有多种抗动脉粥样硬化作用。

方法

将36只雄性日本白兔分为以下几组:普通饮食对照组(C)和赋形剂对照组(V),两组均给予1%胆固醇饮食8周;ARB组(A),给予1%胆固醇饮食8周,在最后4周给予ARB(奥美沙坦,1毫克/千克/天)。

结果

该剂量的奥美沙坦对血压和胆固醇水平均无影响。饮食中的胆固醇导致瓣膜小叶出现脂肪沉积、巨噬细胞积聚和骨桥蛋白共表达,而ARB减少了巨噬细胞积聚(面积百分比:V组,9.3±0.34;A组,1.4±0.30;p = 0.003)和骨桥蛋白表达(p = 0.017)。血管紧张素转换酶在V组中也上调,而奥美沙坦使其降低(p = 0.015)。用抗CD31抗体进行免疫组织化学分析显示,饮食中的胆固醇破坏了瓣膜易发生病变的主动脉侧的内皮完整性,而奥美沙坦则使其得以保留(CD31阳性周长百分比:V组,30±3.7;A组,62±4.8;p = 0.003)。α-平滑肌肌动蛋白阳性肌成纤维细胞的数量在V组中增加,而奥美沙坦使其减少(p = 0.003)。实时聚合酶链反应显示,V组中骨细胞特异性转录因子核心结合因子α-1的信使核糖核酸增加量被奥美沙坦减少。

结论

ARB抑制了喂食胆固醇的兔主动脉瓣的动脉粥样硬化变化,同时保留了内皮完整性,并抑制了瓣膜小叶向肌成纤维细胞和/或成骨细胞的转分化。

相似文献

1
Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits.血管紧张素受体1阻滞剂可抑制高胆固醇血症兔主动脉瓣的动脉粥样硬化改变和内皮损伤。
J Am Coll Cardiol. 2007 Apr 3;49(13):1482-9. doi: 10.1016/j.jacc.2006.11.043. Epub 2007 Mar 21.
2
Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice.规律的运动训练可预防低密度脂蛋白受体缺陷型小鼠的主动脉瓣疾病。
Circulation. 2010 Feb 16;121(6):759-67. doi: 10.1161/CIRCULATIONAHA.109.892224. Epub 2010 Feb 1.
3
Severity of hyperlipidemia does not affect antiatherosclerotic effect of an angiotensin II receptor antagonist in apolipoprotein E-deficient mice.高脂血症的严重程度不影响血管紧张素II受体拮抗剂对载脂蛋白E缺乏小鼠的抗动脉粥样硬化作用。
J Cardiovasc Pharmacol. 2006 Jun;47(6):764-9. doi: 10.1097/01.fjc.0000211788.37658.ad.
4
[Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].[血管紧张素II 1型受体阻滞剂对肝脏甘油三酯代谢的影响:对Zucker肥胖大鼠的实验]
Zhonghua Yi Xue Za Zhi. 2008 Jun 10;88(22):1557-61.
5
Development of aortic valve sclerosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study.动脉粥样硬化兔模型中主动脉瓣硬化的发展:一项免疫组织化学和组织学研究。
J Heart Valve Dis. 2005 May;14(3):365-75.
6
Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice.奥美沙坦和普伐他汀联合使用可减轻 APOE*3Leiden 转基因小鼠动脉粥样硬化的发展。
J Hypertens. 2007 Dec;25(12):2454-62. doi: 10.1097/HJH.0b013e3282ef79f7.
7
Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).奥美沙坦与钙拮抗剂随机对照(OSCAR)研究的原理、设计及患者基线特征:一项比较日本老年高危高血压患者中高剂量血管紧张素II受体阻滞剂(ARB)单药治疗与ARB联合钙通道阻滞剂治疗心血管事件发生率的研究(ClinicalTrials.gov编号:NCT00134160)
Hypertens Res. 2009 Jul;32(7):575-80. doi: 10.1038/hr.2009.60. Epub 2009 May 15.
8
Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.奥美沙坦和普伐他汀对胰岛素抵抗大鼠球囊损伤诱导的新生内膜形成的抑制作用。
Hypertens Res. 2007 Oct;30(10):971-8. doi: 10.1291/hypres.30.971.
9
Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.冠状动脉支架植入成功后加用1型血管紧张素II受体阻滞剂进行降压治疗的安全性和有效性
Hypertens Res. 2009 Jul;32(7):625-30. doi: 10.1038/hr.2009.66. Epub 2009 May 22.
10
Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂与血管紧张素II受体拮抗剂联合应用对易发生心肌梗死的渡边遗传性高脂血症兔一氧化氮生物利用度及动脉粥样硬化改变的影响
Hypertens Res. 2008 Jun;31(6):1199-208. doi: 10.1291/hypres.31.1199.

引用本文的文献

1
Association between blood pressure traits, hypertension, antihypertensive drugs and calcific aortic valve stenosis: a mendelian randomization study.血压特征、高血压、抗高血压药物与钙化性主动脉瓣狭窄之间的关联:一项孟德尔随机化研究
J Geriatr Cardiol. 2025 Mar 28;22(3):351-360. doi: 10.26599/1671-5411.2025.03.008.
2
[Impact of elevated arterial blood pressure on bioprosthetic valve calcification and failure after transcatheter aortic valve replacement].[动脉血压升高对经导管主动脉瓣置换术后生物瓣膜钙化及功能障碍的影响]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Mar 25;54(2):154-160. doi: 10.3724/zdxbyxb-2024-0391.
3
Calcific aortic stenosis: omics-based target discovery and therapy development.
钙化性主动脉瓣狭窄:基于组学的靶点发现与治疗开发。
Eur Heart J. 2025 Feb 14;46(7):620-634. doi: 10.1093/eurheartj/ehae829.
4
Role of Lipoprotein (A) in aortic valve stenosis: Novel disease mechanisms and emerging pharmacotherapeutic approaches.脂蛋白(A)在主动脉瓣狭窄中的作用:新的疾病机制和新兴的药物治疗方法。
Int J Cardiol Heart Vasc. 2024 Oct 30;55:101543. doi: 10.1016/j.ijcha.2024.101543. eCollection 2024 Dec.
5
Models for calcific aortic valve disease in vivo and in vitro.体内和体外钙化性主动脉瓣疾病模型。
Cell Regen. 2024 Mar 1;13(1):6. doi: 10.1186/s13619-024-00189-8.
6
Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA.脂蛋白(a)在主动脉瓣狭窄发病机制中的作用及反义寡核苷酸或短干扰 RNA 治疗方法。
Int J Mol Sci. 2023 Oct 6;24(19):14939. doi: 10.3390/ijms241914939.
7
The Effect of Celecoxib on the Progression of Calcific Aortic Valve Disease-Protective or Pathogenic?塞来昔布对钙化性主动脉瓣疾病进展的影响——保护性还是致病性?
J Clin Med. 2023 Apr 5;12(7):2717. doi: 10.3390/jcm12072717.
8
Calcific aortic valve disease: mechanisms, prevention and treatment.钙化性主动脉瓣疾病:机制、预防和治疗。
Nat Rev Cardiol. 2023 Aug;20(8):546-559. doi: 10.1038/s41569-023-00845-7. Epub 2023 Feb 24.
9
The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease.钙化性主动脉瓣疾病的血流动力学和病理生理机制
Biomedicines. 2022 Jun 3;10(6):1317. doi: 10.3390/biomedicines10061317.
10
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.钙化性主动脉瓣疾病:从分子和细胞机制到医学治疗。
Eur Heart J. 2022 Feb 12;43(7):683-697. doi: 10.1093/eurheartj/ehab757.